Deregulation of IL-37 and its miRNAs modulators in sarcopenic patients after rehabilitation.
Cytokines
IL-37
Inflammaging
MiRNAs
Rehabilitation
Sarcopenia
Journal
Journal of translational medicine
ISSN: 1479-5876
Titre abrégé: J Transl Med
Pays: England
ID NLM: 101190741
Informations de publication
Date de publication:
26 04 2021
26 04 2021
Historique:
received:
26
01
2021
accepted:
12
04
2021
entrez:
27
4
2021
pubmed:
28
4
2021
medline:
15
5
2021
Statut:
epublish
Résumé
sarcopenia is a highly prevalent condition in elderly individuals which is characterized by loss of muscle mass and functions; recent results showed that it is also associated with inflammation. Rehabilitation protocols for sarcopenia are designed to improve physical conditions, but very scarce data are available on their effects on inflammation We verified whether in sarcopenic patients the inflammation is reduced by rehabilitation and investigated the biological correlates of such effect. Twenty-one sarcopenic patients undergoing a specifically-designed rehabilitation program were enrolled in the study. Physical, cognitive and nutritional parameters, as well as the concentration of C-Reactive Protein (CRP), pro-and anti-inflammatory cytokines and cytokine production-modulating miRNAs were measured at the beginning (T Rehabilitation resulted in a significant improvement of physical and cognitive conditions; this was accompanied by a significant reduction of CRP (p = 0.04) as well as of IL-18 (p = 0.008) and IL-37 (p = 0.009) concentration. Notably, the concentration of miR-335-3p (p = 0.007) and miR-657, the two known post-transcriptional regulators of IL-37 production, was increased by the rehabilitation protocol. Results herein confirm that successful rehabilitation for sarcopenia results in a reduction of the inflammatory milieu, raise the possibility that IL-37 may be a key target to monitor the rehabilitation-associated improvement in sarcopenia, and suggest that this cytokine could be a therapeutic target in sarcopenic patients.
Sections du résumé
BACKGROUND
sarcopenia is a highly prevalent condition in elderly individuals which is characterized by loss of muscle mass and functions; recent results showed that it is also associated with inflammation. Rehabilitation protocols for sarcopenia are designed to improve physical conditions, but very scarce data are available on their effects on inflammation We verified whether in sarcopenic patients the inflammation is reduced by rehabilitation and investigated the biological correlates of such effect.
METHODS
Twenty-one sarcopenic patients undergoing a specifically-designed rehabilitation program were enrolled in the study. Physical, cognitive and nutritional parameters, as well as the concentration of C-Reactive Protein (CRP), pro-and anti-inflammatory cytokines and cytokine production-modulating miRNAs were measured at the beginning (T
RESULTS
Rehabilitation resulted in a significant improvement of physical and cognitive conditions; this was accompanied by a significant reduction of CRP (p = 0.04) as well as of IL-18 (p = 0.008) and IL-37 (p = 0.009) concentration. Notably, the concentration of miR-335-3p (p = 0.007) and miR-657, the two known post-transcriptional regulators of IL-37 production, was increased by the rehabilitation protocol.
CONCLUSIONS
Results herein confirm that successful rehabilitation for sarcopenia results in a reduction of the inflammatory milieu, raise the possibility that IL-37 may be a key target to monitor the rehabilitation-associated improvement in sarcopenia, and suggest that this cytokine could be a therapeutic target in sarcopenic patients.
Identifiants
pubmed: 33902634
doi: 10.1186/s12967-021-02830-5
pii: 10.1186/s12967-021-02830-5
pmc: PMC8077701
doi:
Substances chimiques
Cytokines
0
IL37 protein, human
0
Interleukin-1
0
MIRN335 microRNA, human
0
MIRN657 microRNA, human
0
MicroRNAs
0
C-Reactive Protein
9007-41-4
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
172Références
J Gerontol A Biol Sci Med Sci. 2014 Jun;69 Suppl 1:S4-9
pubmed: 24833586
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
J Gerontol A Biol Sci Med Sci. 2006 Oct;61(10):1059-64
pubmed: 17077199
Prev Med. 2008 Oct;47(4):422-6
pubmed: 18672001
J Cell Physiol. 2019 May;234(5):7141-7148
pubmed: 30362558
Nat Immunol. 2015 Apr;16(4):354-65
pubmed: 25729923
Age Ageing. 2019 Jan 1;48(1):16-31
pubmed: 30312372
J Immunol. 2008 Apr 15;180(8):5477-82
pubmed: 18390730
Compr Physiol. 2012 Apr;2(2):1143-211
pubmed: 23798298
Mol Cell. 2002 Aug;10(2):417-26
pubmed: 12191486
Age Ageing. 2005 May;34(3):228-32
pubmed: 15863408
Md State Med J. 1965 Feb;14:61-5
pubmed: 14258950
Curr Opin Immunol. 2012 Aug;24(4):488-93
pubmed: 22565047
Cell Physiol Biochem. 2017;44(1):267-278
pubmed: 29130969
Immunity. 2013 Dec 12;39(6):1003-18
pubmed: 24332029
Dement Neuropsychol. 2017 Jan-Mar;11(1):6-14
pubmed: 29213488
N Engl J Med. 1988 Dec 29;319(26):1701-7
pubmed: 3205267
Aging Clin Exp Res. 2012 Oct;24(5):412-22
pubmed: 22717404
J Appl Physiol (1985). 2003 Nov;95(5):1851-60
pubmed: 14555665
N Engl J Med. 2003 Jan 2;348(1):42-9
pubmed: 12510042
Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2650-5
pubmed: 24481253
Aging Clin Exp Res. 2019 Oct;31(10):1435-1442
pubmed: 30515724
Clin Epidemiol. 2017 Jun 02;9:311-320
pubmed: 28652813
Int J Geriatr Psychiatry. 2015 Sep;30(9):950-6
pubmed: 25565648
Longev Healthspan. 2013 May 02;2(1):8
pubmed: 24472098
Arch Neurol. 2009 Dec;66(12):1447-55
pubmed: 20008648
Front Physiol. 2017 Jun 22;8:434
pubmed: 28690550
Rheumatology (Oxford). 2016 Dec;55(12):2220-2229
pubmed: 27567100
PLoS One. 2014 May 01;9(5):e95346
pubmed: 24788826
J Transl Med. 2014 Mar 16;12:69
pubmed: 24629023
ScientificWorldJournal. 2014;2014:231312
pubmed: 25580454
Age Ageing. 2010 Jul;39(4):412-23
pubmed: 20392703
Medsurg Nurs. 2008 Oct;17(5):343-4
pubmed: 19051984
J Gerontol A Biol Sci Med Sci. 2002 Dec;57(12):M772-7
pubmed: 12456735
J Am Geriatr Soc. 2007 May;55(5):769-74
pubmed: 17493199
Physiol Res. 2014;63(6):683-91
pubmed: 25157651
J Dent Res. 2011 Jul;90(7):830-40
pubmed: 21447699
Kidney Int. 2015 Feb;87(2):396-408
pubmed: 25207880
Nutrition. 1999 Feb;15(2):116-22
pubmed: 9990575
Int J Endocrinol. 2012;2012:127362
pubmed: 22690213
Mech Ageing Dev. 2007 Jan;128(1):92-105
pubmed: 17116321
Nat Commun. 2014 Dec 15;5:5340
pubmed: 25500532
Nat Immunol. 2010 Nov;11(11):1014-22
pubmed: 20935647
Allergy. 2015 Apr;70(4):366-73
pubmed: 25557042
J Physiol. 2012 Mar 1;590(5):1077-84
pubmed: 22289907
J Am Med Dir Assoc. 2018 Dec;19(12):1063-1068
pubmed: 30206033
Biogerontology. 2010 Oct;11(5):537-45
pubmed: 20697813
J Gerontol A Biol Sci Med Sci. 2009 Nov;64(11):1183-9
pubmed: 19622801
Biomed Res Int. 2017;2017:2672435
pubmed: 28421192
Aging Clin Exp Res. 2019 Jul;31(7):917-925
pubmed: 30191453
Clin Exp Immunol. 2015 Sep;181(3):480-90
pubmed: 25693732
Redox Biol. 2015;4:296-307
pubmed: 25625584